Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs) (Seva)

This study is not yet open for participant recruitment.
Verified October 2013 by Center for Health Enhancement System Studies
Sponsor:
Collaborators:
Dartmouth-Hitchcock Medical Center
Partnership Health Center
Access Community Health Center
Information provided by (Responsible Party):
Andrew Quanbeck, Center for Health Enhancement System Studies
ClinicalTrials.gov Identifier:
NCT01963234
First received: October 9, 2013
Last updated: October 11, 2013
Last verified: October 2013

October 9, 2013
October 11, 2013
February 2014
June 2017   (final data collection date for primary outcome measure)
Implementation status [ Time Frame: up to 3 years ] [ Designated as safety issue: No ]
To measure implementation progress, we will adapt our implementation model intervention into a specific implementation plan (including timetables) for each clinic. We employ the Stages of Implementation Completion model (Chamberlain et al., 2011) to assess the degree of implementation. Each of the 8 phases of the implementation completion model is prospectively broken down into discrete tasks and events. We will assess whether each task/event was implemented and the length of time each one took to implement. Starting at the beginning of the implementation planning period (4 months before the first patient accesses Seva), the checklist will be reviewed and updated monthly by the implementation program leader, with responses verified by the clinic coach.
Same as current
Complete list of historical versions of study NCT01963234 on ClinicalTrials.gov Archive Site
  • Number of patients using system [ Time Frame: up to 3 years ] [ Designated as safety issue: No ]
  • Clinical adoption [ Time Frame: up to 3 years ] [ Designated as safety issue: No ]
    We will analyze computerized system log files to produce metrics about patterns of system adoption by patients and staff. We will assess the characteristics of staff members (job function, years with clinic, etc.) and patients (age, gender, race, etc.) to determine individual characteristics associated with the degree of adoption.
Same as current
Not Provided
Not Provided
 
Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs)
Implementing Technology-Assisted Drug Treatment and Relapse Prevention in Federally Qualified Health Centers (FQHCs)

The purpose of the research is to study the impact of a recovery support system called Seva on primary care organizations, where issues such as coordination of care, job satisfaction, and the cost of adopting and operating new technologies are critical. The study will also investigate how to best implement this kind of technology into health care delivery systems that care for people diagnosed with substance abuse.

Not Provided
Interventional
Not Provided
Not Provided
  • Substance Use Disorders
  • HIV
Other: Implementation model
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
Not Provided
Not Provided
June 2017   (final data collection date for primary outcome measure)

Inclusion Criteria:

Patient subjects must be 1) age 18 or older 2) be identified with a new drug treatment episode, and 3) meet criteria for Substance Use Disorder (SUD) according to the National Institute on Drug Abuse's modified-ASSIST screening instrument. Clinician subjects referring patients will ensure that patients: 4) have no current psychotic disorder severe enough to prevent participation, 5) have no acute medical problem requiring immediate inpatient treatment, 6) are willing to use Seva, and 7) can understand and sign a consent form in English.

Clinician subjects include MDs, behavioral health providers, nurses and management staff from the clinics' primary care and behavioral health departments. Clinician must have an interest in the research objectives.

Exclusion Criteria:

  • Failure to meet inclusion criteria above will exclude participants from participating.
Both
18 Years and older
Not Provided
Contact: Fiona M McTavish, MS 608-262-7852 fiona.mctavish@chess.wisc.edu
Contact: Andrew R Quanbeck, Ph.D. 608-890-1016 andrew.quanbeck@chess.wisc.edu
United States
 
NCT01963234
R01 DA034279-01
Yes
Andrew Quanbeck, Center for Health Enhancement System Studies
Center for Health Enhancement System Studies
  • National Institute on Drug Abuse (NIDA)
  • Dartmouth-Hitchcock Medical Center
  • Partnership Health Center
  • Access Community Health Center
Not Provided
Center for Health Enhancement System Studies
October 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP